Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.
Over millions and millions of years, a collection of reward systems
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.
Accompany Health provides comprehensive in-home care to patients who live in sometimes underserved regions.
Basking Biosciences is to commercialize technology developed at Duke and Ohio State Universities.
Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
Magnet Biomedicine is a biotechnology research platform specializing in discovering true molecular glues.
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
Recuro Health offers a holistic suite of virtual care services and supplemental benefits.
Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.
Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.
ARCH Venture Partners has invested in 239 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
ARCH Venture Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Medical. The firm invests across 19 different industry categories.
Among tracked funding rounds, Xaira Therapeutics received $1.0B in a Series A round. ARCH Venture Partners's total known invested capital is $31.3B.
ARCH Venture Partners's average investment size is $131.1M across its portfolio of 239 companies.
Recent ARCH Venture Partners portfolio additions include Xaira Therapeutics, Matter Neuroscience, Areteia Therapeutics, Proniras, Accompany Health. These companies were founded in 2020 or later.